A Mechanistic Understanding of Allosteric Immune Escape Pathways in the HIV-1 Envelope Glycoprotein

PLoS Computational Biology

Volumn 9, Issue 5, 2013, Pages

  Sethi, Anurag ^a,b   Tian, Jianhui ^a   Derdeyn, Cynthia A ^c,d   Korber, Bette ^a,e   Gnanakaran, S ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b CENTER FOR NONLINEAR STUDIES   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; GLYCOPROTEINS; PRINCIPAL COMPONENT ANALYSIS;

ANALYSIS-BASED APPROACHES; ANTIBODY BINDING SITES; COMMUNICATION PATHWAYS; CORRELATION COMPONENTS; DYNAMICS SIMULATION; ENVELOPE GLYCOPROTEINS; HIGH MUTATION RATE; MECHANISTICS; NEUTRALIZING ANTIBODIES; PROTEINS STRUCTURES;

MOLECULAR DYNAMICS;

GLYCOPROTEIN GP 120; NEUTRALIZING ANTIBODY; PROTEIN ANTIBODY;

ALLOSTERISM; AMINO ACID SEQUENCE; ARTICLE; CLADISTICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE SYSTEM; MOLECULAR DYNAMICS; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIMULATION; STRUCTURAL HOMOLOGY; VIRUS CELL INTERACTION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84878477071     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003046     Document Type: Article

References (109)

1. Zhou T, Georgiev I, Wu X, Yang ZY, Dai K, et al. (2010) Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329: 811-817.
2. Pejchal R, Doores KJ, Walker LM, Khayat R, Huang PS, et al. (2011) A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 334: 1097-1103.
3. McLellan JS, Pancera M, Carrico C, Gorman J, Julien JP, et al. (2011) Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480: 336-343.
4. Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, et al. (2012) Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial. New England Journal of Medicine 366: 1275-1286.
5. Tomaras GD, Haynes BF, (2009) HIV-1-specific antibody responses during acute and chronic HIV-1 infection. Curr Opin HIV AIDS 4: 373-379.
6. Rong R, Li B, Lynch RM, Haaland RE, Murphy MK, et al. (2009) Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS pathogens 5: e1000594.
7. Zolla-Pazner S, Cardozo T, (2010) Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design. Nature reviews Immunology 10: 527-535.
8. Moore PL, Ranchobe N, Lambson BE, Gray ES, Cave E, et al. (2009) Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection. PLoS pathogens 5: e1000598.
9. Bar KJ, Tsao C-y, Iyer SS, Decker JM, Yang Y, et al. (2012) Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape. PLoS pathogens 8: e1002721.
10. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, et al. (2001) Evolutionary and immunological implications of contemporary HIV-1 variation. British medical bulletin 58: 19-42.
11. Perelson AS, Ribeiro RM, (2008) Estimating drug efficacy and viral dynamic parameters: HIV and HCV. Statistics in medicine 27: 4647-4657.
12. Robertson DL, Hahn BH, Sharp PM, (1995) Recombination in AIDS viruses. Journal of molecular evolution 40: 249-259.
13. Rambaut A, Posada D, Crandall KA, Holmes EC, (2004) The causes and consequences of HIV evolution. Nature reviews Genetics 5: 52-61.
14. Wei XP, Decker JM, Wang SY, Hui HX, Kappes JC, et al. (2003) Antibody neutralization and escape by HIV-1. Nature 422: 307-312.
15. Bar KJ, Tsao CY, Iyer SS, Decker JM, Yang Y, et al. (2012) Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS pathogens 8: e1002721.
16. Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, et al. (2010) Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 5: e12303.
17. McCutchan FE, (2000) Understanding the genetic diversity of HIV-1. AIDS 14 Suppl 3: S31-44.
18. Thomson MM, Perez-Alvarez L, Najera R, (2002) Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. The Lancet infectious diseases 2: 461-471.
19. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, et al. (2000) HIV-1 nomenclature proposal. Science 288: 55-56.
20. Gnanakaran S, Daniels MG, Bhattacharya T, Lapedes AS, Sethi A, et al. (2010) Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies. Plos Computational Biology 6: e1000955.
21. Kern D, Zuiderweg ER, (2003) The role of dynamics in allosteric regulation. Current opinion in structural biology 13: 748-757.
22. Hilser VJ, (2010) Biochemistry. An ensemble view of allostery. Science 327: 653-654.
23. Miyashita O, Onuchic JN, Wolynes PG, (2003) Nonlinear elasticity, proteinquakes, and the energy landscapes of functional transitions in proteins. Proceedings of the National Academy of Sciences of the United States of America 100: 12570-12575.
24. Frauenfelder H, McMahon BH, Austin RH, Chu K, Groves JT, (2001) The role of structure, energy landscape, dynamics, and allostery in the enzymatic function of myoglobin. Proceedings of the National Academy of Sciences of the United States of America 98: 2370-2374.
25. Cui Q, Karplus M, (2008) Allostery and cooperativity revisited. Protein science: a publication of the Protein Society 17: 1295-1307.
26. Bahar I, Lezon TR, Yang LW, Eyal E, (2010) Global dynamics of proteins: bridging between structure and function. Annual review of biophysics 39: 23-42.
27. Mitternacht S, Berezovsky IN, (2011) Binding leverage as a molecular basis for allosteric regulation. Plos Computational Biology 7: e1002148.
28. Gnanakaran S, Bhattacharya T, Daniels M, Keele BF, Hraber PT, et al. (2011) Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections. PLoS pathogens 7: e1002209.
29. Kirchherr JL, Hamilton J, Lu X, Gnanakaran S, Muldoon M, et al. (2011) Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120. Virology 409: 163-174.
30. Gnanakaran S, Lang D, Daniels M, Bhattacharya T, Derdeyn CA, et al. (2007) Clade-specific differences between human immunodeficiency virus type 1 clades B and C: diversity and correlations in C3-V4 regions of gp120. Journal of virology 81: 4886-4891.
31. Lynch RM, Shen T, Gnanakaran S, Derdeyn CA, (2009) Appreciating HIV type 1 diversity: subtype differences in Env. AIDS research and human retroviruses 25: 237-248.
32. Rong R, Gnanakaran S, Decker JM, Bibollet-Ruche F, Taylor J, et al. (2007) Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. Journal of virology 81: 5658-5668.
33. Lu M, Blacklow SC, Kim PS, (1995) A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature structural biology 2: 1075-1082.
34. Bahar I, Lezon TR, Bakan A, Shrivastava IH, (2010) Normal mode analysis of biomolecular structures: functional mechanisms of membrane proteins. Chemical reviews 110: 1463-1497.
35. Kong L, Huang CC, Coales SJ, Molnar KS, Skinner J, et al. (2010) Local conformational stability of HIV-1 gp120 in unliganded and CD4-bound states as defined by amide hydrogen/deuterium exchange. Journal of virology 84: 10311-10321.
36. Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, et al. (2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420: 678-682.
37. Pancera M, Majeed S, Ban YE, Chen L, Huang CC, et al. (2010) Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility. Proceedings of the National Academy of Sciences of the United States of America 107: 1166-1171.
38. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, et al. (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384: 179-183.
39. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, et al. (1996) Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. Journal of virology 70: 1100-1108.
40. Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, et al. (1987) Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237: 1351-1355.
41. Guttman M, Kahn M, Garcia NK, Hu SL, Lee KK, (2012) Solution Structure, Conformational Dynamics, and CD4-Induced Activation in Full-Length, Glycosylated, Monomeric HIV gp120. Journal of virology 86: 8750-8764.
42. Myszka DG, Sweet RW, Hensley P, Brigham-Burke M, Kwong PD, et al. (2000) Energetics of the HIV gp120-CD4 binding reaction. Proceedings of the National Academy of Sciences of the United States of America 97: 9026-9031.
43. Gray ES, Moody MA, Wibmer CK, Chen X, Marshall D, et al. (2011) Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual. Journal of virology 85: 7719-7729.
44. Diskin R, Marcovecchio PM, Bjorkman PJ, (2010) Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity. Nature structural & molecular biology 17: 608-613.
45. Gray ES, Moody MA, Wibmer CK, Chen X, Marshall D, et al. (2011) Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and reprsents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual. Journal of virology 85: 7719-7729.
46. Moore PL, Ranchobe N, Lambson BE, Gray ES, Cave E, et al. (2009) Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS pathogens 5: e1000598.
47. Bar KJ, Tsao C-Y, Iyer SS, Decker JM, Yang Y, et al. (2012) Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS pathogens 8: e1002721.
48. Murphy MK, Yue L, Pan R, Boliar S, Sethi A, et al. (2013) Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth. PLoS pathogens 9: e1003173.
49. Bahar I, Chennubhotla C, Tobi D, (2007) Intrinsic dynamics of enzymes in the unbound state and relation to allosteric regulation. Current opinion in structural biology 17: 633-640.
50. Berendsen HJ, Hayward S, (2000) Collective protein dynamics in relation to function. Current opinion in structural biology 10: 165-169.
51. Ma J, (2005) Usefulness and limitations of normal mode analysis in modeling dynamics of biomolecular complexes. Structure 13: 373-380.
52. Petrone P, Pande VS, (2006) Can conformational change be described by only a few normal modes? Biophysical journal 90: 1583-1593.
53. Amaro RE, Sethi A, Myers RS, Davisson VJ, Luthey-Schulten ZA, (2007) A network of conserved interactions regulates the allosteric signal in a glutamine amidotransferase. Biochemistry 46: 2156-2173.
54. Micheletti C, Carloni P, Maritan A, (2004) Accurate and efficient description of protein vibrational dynamics: comparing molecular dynamics and Gaussian models. Proteins 55: 635-645.
55. Micheletti C, (2012) Comparing proteins by their internal dynamics: Exploring structure-function relationships beyond static structural alignments. Physics of Life Reviews pii S1571-064500132-137. doi:10.1016/j.plrev.2012.1010.1009.
56. Munz M, Lyngso R, Hein J, Biggin PC, (2010) Dynamics based alignment of proteins: an alternative approach to quantify dynamic similarity. BMC bioinformatics 11: 188.
57. Pang A, Arinaminpathy Y, Sansom MS, Biggin PC, (2005) Comparative molecular dynamics-similar folds and similar motions? Proteins 61: 809-822.
58. Rod TH, Radkiewicz JL, Brooks CL 3rd, (2003) Correlated motion and the effect of distal mutations in dihydrofolate reductase. Proceedings of the National Academy of Sciences of the United States of America 100: 6980-6985.
59. Shulman AI, Larson C, Mangelsdorf DJ, Ranganathan R, (2004) Structural determinants of allosteric ligand activation in RXR heterodimers. Cell 116: 417-429.
60. Suel GM, Lockless SW, Wall MA, Ranganathan R, (2003) Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nature structural biology 10: 59-69.
61. Chennubhotla C, Bahar I, (2006) Markov propagation of allosteric effects in biomolecular systems: application to GroEL-GroES. Molecular systems biology 2: 36.
62. Sathyapriya R, Vishveshwara S, (2007) Structure networks of E. coli glutaminyl-tRNA synthetase: effects of ligand binding. Proteins 68: 541-550.
63. Sethi A, Eargle J, Black AA, Luthey-Schulten Z, (2009) Dynamical networks in tRNA:protein complexes. Proceedings of the National Academy of Sciences of the United States of America 106: 6620-6625.
64. del Sol A, Fujihashi H, Amoros D, Nussinov R, (2006) Residues crucial for maintaining short paths in network communication mediate signaling in proteins. Molecular systems biology 22006 0019.
65. Vanwart AT, Eargle J, Luthey-Schulten Z, Amaro RE, (2012) Exploring residue component contributions to dynamical network models of allostery. Journal of chemical theory and computation 8: 2949-2961.
66. Ravasz E, Gnanakaran S, Toroczkai Z (2008) Network Structure of Protein Folding Pathways. arXiv: 0705.0912v0701.
67. Bouvignies G, Bernado P, Meier S, Cho K, Grzesiek S, et al. (2005) Identification of slow correlated motions in proteins using residual dipolar and hydrogen-bond scalar couplings. Proceedings of the National Academy of Sciences of the United States of America 102: 13885-13890.
68. Rivalta I, Sultan MM, Lee NS, Manley GA, Loria JP, et al. (2012) Allosteric pathways in imidazole glycerol phosphate synthase. Proceedings of the National Academy of Sciences of the United States of America 109: E1428-1436.
69. Gasper PM, Fuglestad B, Komives EA, Markwick PR, McCammon JA, (2012) Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities. Proceedings of the National Academy of Sciences of the United States of America 109: 21216-21222.
70. Huang CC, Venturi M, Majeed S, Moore MJ, Phogat S, et al. (2004) Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proceedings of the National Academy of Sciences of the United States of America 101: 2706-2711.
71. Kwong PD, Wyatt R, Majeed S, Robinson J, Sweet RW, et al. (2000) Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure 8: 1329-1339.
72. Hemelaar J, Gouws E, Ghys PD, Osmanov S, (2011) Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25: 679-689.
73. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM, (2008) Medical progress: The challenge of HIV-1 subtype diversity. New England Journal of Medicine 358: 1590-1602.
74. Plantier J-C, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, et al. (2009) A new human immunodeficiency virus derived from gorillas. Nature Medicine 15: 871-872.
75. McCutchan FE, (2006) Global epidemiology of HIV. Journal of medical virology 78 Suppl 1: S7-S12.
76. Chen B, Vogan EM, Gong H, Skehel JJ, Wiley DC, et al. (2005) Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433: 834-841.
77. Liu J, Bartesaghi A, Borgnia MJ, Sapiro G, Subramaniam S, (2008) Molecular architecture of native HIV-1 gp120 trimers. Nature 455: 109-113.
78. Kwon YD, Finzi A, Wu X, Dogo-Isonagie C, Lee LK, et al. (2012) Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proceedings of the National Academy of Sciences of the United States of America 109: 5663-5668.
79. Chennubhotla C, Bahar I, (2007) Signal propagation in proteins and relation to equilibrium fluctuations. Plos Computational Biology 3: 1716-1726.
80. del Sol A, Tsai CJ, Ma B, Nussinov R, (2009) The origin of allosteric functional modulation: multiple pre-existing pathways. Structure 17: 1042-1050.
81. Daily MD, Upadhyaya TJ, Gray JJ, (2008) Contact rearrangements form coupled networks from local motions in allosteric proteins. Proteins 71: 455-466.
82. Ghosh A, Vishveshwara S, (2007) A study of communication pathways in methionyl- tRNA synthetase by molecular dynamics simulations and structure network analysis. Proceedings of the National Academy of Sciences of the United States of America 104: 15711-15716.
83. Langfelder P, Luo R, Oldham MC, Horvath S, (2011) Is My Network Module Preserved and Reproducible? Plos Computational Biology 7: e1001057.
84. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, et al. (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763-767.
85. Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, et al. (2007) Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445: 732-737.
86. Sattentau QJ, Dalgleish AG, Weiss RA, Beverley PC, (1986) Epitopes of the CD4 antigen and HIV infection. Science 234: 1120-1123.
87. Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, et al. (2011) Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333: 1633-1637.
88. Zhang M, Xiao X, Sidorov IA, Choudhry V, Cham F, et al. (2004) Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. Journal of virology 78: 9233-9242.
89. Kessler JA II, McKenna PM, Emini EA, Chan CP, Patel MD, et al. (2009) Recombinant human monoclonal antibody IGG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates. AIDS research and human retroviruses 13: 575-582.
90. Chen L, Kwon YD, Zhou T, Wu X, O'Dell S, et al. (2009) Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120. Science 326: 1123-1127.
91. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, et al. (1998) Structure of an hIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing antibody. Nature 393: 648-659.
92. Harris A, Borgnia MJ, Shi D, BArtesaghi A, He H, et al. (2011) Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quartenary molecular architectures. Proceedings of the National Academy of Sciences of the United States of America 108: 11440-11445.
93. West AP Jr, Diskin R, Nussenzweig MC, Bjorkman PJ, (2012) Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120. Proceedings of the National Academy of Sciences of the United States of America 109: E2083-E2090.
94. Gaschen B, Taylor J, Yusim K, Foley B, Gao F, et al. (2002) Diversity considerations in HIV-1 vaccine selection. Science 296: 2354-2360.
95. Frost SDW, Liu Y, Pond K, Chappey C, Wrin T, et al. (2005) Characterization of human imunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. Journal of virology 79: 6523-6527.
96. Mitternacht S, Berezovsky IN, (2011) Coherent conformational degrees of freedom as a structural basis for allosteric communication. Plos Computational Biology 7: e1002301.
97. Leitner DM, (2008) Energy flow in proteins. Annual review of physical chemistry 59: 233-259.
98. Goo L, Milligan C, Simonich CA, Nduati R, Overbaugh J, (2012) Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitodes in envelope. Journal of virology 86: 9566-9582.
99. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, et al. (2001) Comparative Protein Structure Modeling Using MODELLER. Current Protocols in Protein Science Chapter 2Unit 2.9. doi:10.1002/0471140864.ps0209s50.
100. Mark P, Nilsson L, (2001) Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K. The Journal of Physical Chemistry A 105: 9954-9960.
101. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, et al. (2005) Scalable molecular dynamics with NAMD. Journal of Computational Chemistry 26: 1781-1802.
102. MacKerell AD, Bashford D, Bellott, Dunbrack RL, Evanseck JD, et al. (1998) All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins†. The Journal of Physical Chemistry B 102: 3586-3616.
103. Eargle J, Black AA, Sethi A, Trabuco LG, Luthey-Schulten Z, (2008) Dynamics of Recognition between tRNA and Elongation Factor Tu. Journal of molecular biology 377: 1382-1405.
104. Darden T, York D, Pederson L, (1993) Particle mesh Ewald: An N•log(N) method for Ewald sums in large systems. Journal of Chemical Physics 98: 10089-10092.
105. Hans CA, (1983) Rattle: A "velocity'" version of the shake algorithm for molecular dynamics calculations. Journal of Computational Physics 52: 24-34.
106. Miyamoto S, Kollman PA, (1992) Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. Journal of Computational Chemistry 13: 952-962.
107. Glykos NM, (2006) Software news and updates. Carma: a molecular dynamics analysis program. Journal of Computational Chemistry 27: 1765-1768.
108. Girvan M, Newman ME, (2002) Community structure in social and biological networks. Proceedings of the National Academy of Sciences of the United States of America 99: 7821-7826.
109. Trabuco LG, Villa E, Mitra K, Frank J, Schulten K, (2008) Flexible Fitting of Atomic Structures into Electron Microscopy Maps Using Molecular Dynamics. Structure 16: 673-683.